Back to top
more

Molina Healthcare (MOH)

(Delayed Data from NYSE)

$327.48 USD

327.48
408,609

-3.64 (-1.10%)

Updated Sep 6, 2024 04:00 PM ET

After-Market: $327.85 +0.37 (0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 15% (212 out of 249)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Has Axonics (AXNX) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Axonics Modulation Technologies (AXNX) and Molina (MOH) have performed compared to their sector so far this year.

Debasmita Chatterjee headshot

4 HMO Stocks to Watch Despite Escalating Technology Expenses

by Debasmita Chatterjee

A growing customer base and numerous contract wins might drive the Medical-HMO industry. However, high expenses related to technology advancements and a shortage of nurses will dampen margins. Stocks like UNH, HUM, CNC and MOH will likely ride out the industry storms.

Centene (CNC) Wins Contract to Serve Texas' Foster Population

by Zacks Equity Research

Centene's (CNC) Texas subsidiary secures a contract to continue catering to the state's foster children and youth via its Medicaid plans.

Encompass Health (EHC) Opens New 50-Bed Hospital in Naples

by Zacks Equity Research

With the new facility in Naples, Encompass Health (EHC) now has 153 inpatient rehabilitation units in total.

Humana (HUM) Hikes Guidance: Here's Why It's a Good Sign

by Zacks Equity Research

Humana (HUM) shaking off the discrete COVID-19 headwind from its guidance is an important milestone for the Medical - HMOs space.

Are Investors Undervaluing Molina Healthcare (MOH) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

HCA Healthcare (HCA) Invests in VitalConnect's Remote Monitoring

by Zacks Equity Research

HCA Healthcare's (HCA) investment is likely to advance technology in the medical space, helping patients as well as professionals.

Is Molina Healthcare (MOH) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Molina (MOH) and DocGo Inc. (DCGO) have performed compared to their sector so far this year.

Here's How Much a $1000 Investment in Molina Made 10 Years Ago Would Be Worth Today

by Zacks Equity Research

Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Molina Healthcare (MOH) to Get New Medicaid Contract in Iowa

by Zacks Equity Research

Molina Healthcare's (MOH) Iowa health plan is likely to commence on Jul 1 next year.

Cigna (CI) to Widen Access to Individual Health Plans in 2023

by Zacks Equity Research

Cigna (CI) unveils enhanced individual and family health plans for its customers to opt for in the 2023 Open Enrollment Period. CI will enter newer counties and states to offer better health outcomes.

Is Molina Healthcare (MOH) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Centene (CNC) Wins Medi-Cal Contracts but Loses 3 Counties

by Zacks Equity Research

Centene (CNC) is likely to appeal the decision to avoid disruption in services and it has time until Sep 1, 2022, to do so.

QIAGEN's (QGEN) New Syndromic Test to Combat Monkeypox Spread

by Zacks Equity Research

QIAGEN (QGEN) joins the global fight against monkeypox with the launch of its novel QIAstat-Dx Viral Vesicular Panel RUO.

Teleflex (TFX) Hit by Urolift Volume Decline, Cost Pressure

by Zacks Equity Research

In the Americas, growth within the Surgical business of Teleflex (TFX) is offset by a decline in Interventional Urology.

Here's How Much You'd Have If You Invested $1000 in Molina a Decade Ago

by Zacks Equity Research

Holding on to popular or trending stocks for the long-term can make your portfolio a winner.

Edwards Lifesciences (EW) Gets CE Mark for PASCAL Precision

by Zacks Equity Research

Edwards Lifesciences' (EW) PASCAL Precision system enables precise navigation and implant delivery during mitral and tricuspid regurgitation treatment.

Here's Why Investors Should Retain Hologic (HOLX) Stock for Now

by Zacks Equity Research

Investors are optimistic about Hologic's (HOLX) better-than-expected results and expanded Panther installed base.

IDEXX (IDXX) Suffers From Macro Headwinds, Cost Constraints

by Zacks Equity Research

The strengthening of the rate of exchange for the U.S. dollar relative to other currencies has a negative impact on IDEXX's (IDXX) revenues.

What's in the Cards for Medtronic (MDT) in Q1 Earnings?

by Zacks Equity Research

Going by the industry-wide macro trend, we expect Medtronic (MDT) to once again report an adverse effect related to the global supply chain issues in fiscal Q1.

Boston Scientific (BSX) Signs Obsidio-Acquisition Agreement

by Zacks Equity Research

Boston Scientific's (BSX) latest acquisition will add the FDA-approved GEM technology to its interventional oncology and embolization portfolio.

Here's Why Investors Should Retain STERIS (STE) Stock for Now

by Zacks Equity Research

Investors are optimistic about STERIS' (STE) robust segmental performance and Cantel Medical buyout.

Humana (HUM) to Acquire Inclusa to Aid Medicaid Customer Base

by Zacks Equity Research

Humana (HUM) inks a deal to purchase Wisconsin-based Inclusa to grow its Medicaid membership and fortify its footprint in the state.

Cigna (CI) & Oscar Health Boost Presence in Philadelphia

by Zacks Equity Research

Cigna (CI) & Oscar Health's plans are likely to target businesses with 1-50 employees.